1205286

Solesence, Inc. — FEI 3003574860

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 13, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Romeoville, IL (United States)